• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    ACADIA Pharmaceuticals Inc. (ACAD)

    -NasdaqGS
    19.36 Down 0.93(4.58%) Feb 5, 4:00PM EST
    |After Hours : 19.36 0.00 (0.00%) Feb 5, 7:17PM EST
    Prev Close:20.29
    Open:19.90
    Bid:17.50 x 100
    Ask:21.00 x 100
    1y Target Est:48.20
    Beta:3.10231
    Earnings Date:Feb 24 - Feb 29 (Est.)
    Day's Range:19.23 - 20.62
    52wk Range:17.52 - 51.99
    Volume:2,686,737
    Avg Vol (3m):1,724,180
    Market Cap:2.15B
    P/E (ttm):N/A
    EPS (ttm):-1.48
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACAD

    Comparison

    Symbol% ChgMkt Cap
    ACADDown 4.58%2.15B
    AZNDown 1.44%75.92B
    PFEUp 0.10%179.22B
    LLYUp 0.05%78.70B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):22,255.26
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.58
    Quarterly EPS Est (Dec-15) :-0.40
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.64

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback